Navigation Links
Neuralstem Reports Second Quarter Financial Results and Highlights
Date:8/14/2008

plications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10- KSB for the year ended December 31, 2007 and the quarterly report on form 10-Q for the period ended June 30, 2008.


'/>"/>
SOURCE Neuralstem Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Neuralstem Fills Key Product Development Position
2. Neuralstem Responds to New StemCells, Inc. Lawsuit
3. Neuralstem Sues StemCells, Inc. Over New Patent
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
6. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
7. Neuralstem Shares Accepted for Trading on Amex(R)
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
10. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
11. Senetek PLC Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... TORONTO, Sept. 6, 2011 Generex Biotechnology Corporation ( ... of the Company,s reorganization plan and following a comprehensive ... assessment, the Company has completed the sales of two ... proceeds of just over $1,000,000.  The tenanted properties were ...
... 2011 The Immune Deficiency Foundation (IDF) announced today ... (CE) course for  nurses. The goal of this CE ... providing an educational update on primary immunodeficiency disease and ... national patient organization dedicated to improving the diagnosis, treatment ...
... OXIS International, Inc. (OTC Bulletin Board: OXIS ... Saloff as Chief Executive Officer.  Mr. Saloff was appointed to ... "David,s proven ability to move companies from development stage ... OXIS at this time," said Anthony J. Cataldo, Chairman of ...
Cached Biology Technology:Generex Augments Cash Position With Sales of Non-Essential Assets 2Generex Augments Cash Position With Sales of Non-Essential Assets 3Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy 2Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy 3OXIS International Names David Saloff as Chief Executive Officer 2OXIS International Names David Saloff as Chief Executive Officer 3
(Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
(Date:4/17/2014)... German . ... also provide us with a continuous stream of information about ... sit still in a car the world glides by ... Seemingly without effort, our brain calculates self-motion from this "optic ... a steady gaze during our own movements. Together with biologists ...
(Date:4/17/2014)... House honored Clemson professor Rajendra Singh Thursday as ... promote and expand solar deployment in the residential, ... Houser Banks Professor of Electrical and Computer Engineering ... is considered a local hero leading the charge ... opportunity in solar power and driving policy changes ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... news media splash photos of the company,s CEO around the ... Research the shape of the CEO,s face evokes judgments about ... what face is put on the crisis, and [our] research ... a trivial consideration," say authors Gerald J. Gorn, Yuwei Jiang ...
... Medical Research, led by Jos Luis Milln, Ph.D., have ... replacement therapy to prevent hypophosphatasia (HPP), a primary skeletal ... foundation for future clinical trials for HPP patients. ... that most commonly results from a lack of vitamin ...
... direct communication links between the human brain and ... themselves to changing environmental conditions, or computer chips ... medical technologies that eliminate currently untreatable conditions such ... these developments occurring at the same time. Far-fetched? ...
Cached Biology News:Potential therapy discovered for hypophosphatasia, a congenital form of rickets 2The coming convergence 2The coming convergence 3
... mutS are mismatch repair minus strains of ... repair of the newly synthesized unmethylated strand ... making them helpful in such systems as ... Systems. Both ES1301 and BMH 71-18 mutS ...
1 unit is sufficient for 1 caspase activity assay....
RABBIT ANTI WARFARIN...
Request Info...
Biology Products: